Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
Holding MYO?
Track your performance easily
MYO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.51 - $7.17
Previous CloseN/A
Volume192.17K
Average Volume (3M)432.73K
Market Cap
$202.80M
Enterprise Value$145.79M
Total Cash (Recent Filing)$797.17K
Total Debt (Recent Filing)$3.38M
Price to Earnings (P/E)―
Beta1.98
Next Earnings
Mar 06, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding33,245,870
10 Day Avg. Volume543,798
30 Day Avg. Volume432,734
Standard Deviation0.34
R-Squared0.07
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.31
Price to Cash Flow (P/CF)-30.90
P/FCF Ratio0.00
Enterprise Value/Market Cap0.72
Enterprise Value/Revenue5.70
Enterprise Value/Gross Profit11.06
Enterprise Value/Ebitda-20.17
Forecast
1Y Price Target
$8.25Price Target Upside35.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Myomo News
PremiumCompany Announcements
Myomo, Inc. Reports Record Third Quarter Growth
Ownership Overview
16.38% Insiders
5.26% Mutual Funds
0.99% Other Institutional Investors
73.52% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MYO FAQ
What was Myomo Inc’s price range in the past 12 months?
Myomo Inc lowest stock price was $2.51 and its highest was $7.17 in the past 12 months.
What is Myomo Inc’s market cap?
Myomo Inc’s market cap is $202.80M.
When is Myomo Inc’s upcoming earnings report date?
Myomo Inc’s upcoming earnings report date is Mar 06, 2025 which is in 44 days.
How were Myomo Inc’s earnings last quarter?
Myomo Inc released its earnings results on Nov 06, 2024. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.042 by $0.012.
Is Myomo Inc overvalued?
According to Wall Street analysts Myomo Inc’s price is currently Undervalued.
Does Myomo Inc pay dividends?
Myomo Inc does not currently pay dividends.
What is Myomo Inc’s EPS estimate?
Myomo Inc’s EPS estimate is -0.02.
How many shares outstanding does Myomo Inc have?
Myomo Inc has 33,245,870 shares outstanding.
What happened to Myomo Inc’s price movement after its last earnings report?
Myomo Inc reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.042. Following the earnings report the stock price went up 20.096%.
Which hedge fund is a major shareholder of Myomo Inc?
Currently, no hedge funds are holding shares in MYO
---
Myomo Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.25 (35.25% Upside)
$8.25 (35.25% Upside)
Blogger Sentiment
Bullish
MYO Sentiment 70%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 25.9%
Last 30 Days ▲ 25.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.78%
12-Months-Change
Fundamentals
Return on Equity
-82.54%
Trailing 12-Months
Asset Growth
-4.35%
Trailing 12-Months
Company Description
Myomo Inc
Myomo, Inc. is a medical robotics company, which offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It offers MyoPro, which is a myoelectric elbow, wrist, and hand orthosis that supports an impaired hand and arm while also enabling it to move again. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Cambridge, MA.
---
MYO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong quarter with record revenues and significant growth in key areas such as Medicare Part B patients and the O&P channel. However, challenges with Medicare Advantage reimbursements and increased operating expenses were notable concerns.Read More>---
MYO Stock 12 Month Forecast
Average Price Target
$8.25
▲(35.25% Upside)
Technical Analysis
NovaBay Pharma
―
Nemaura Medical
―
Oragenics
―
Veracyte
―
Butterfly Network
―
Electrocore
―
Best Analysts Covering MYO
1 Year
1 Year Success Rate
8/10 ratings generated profit
1 Year Average Return
+164.98%
reiterated a buy rating 2 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +164.98% per trade.
---